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Abstract
Background: Colorectal cancer (CRC) diagnosed at <50 years is predominantly located in the distal colon and
rectum. Little is known about which lesion subtypes may serve as CRC precursors in young adults. The aim of this
work was to document the prevalence and histological subtype of lesions seen in patients aged <50 years, and any
associated clinical features.
Methods: An audit of the colonoscopy database at The Queen Elizabeth Hospital in Adelaide, South Australia over
a 12-month period was undertaken. Findings were recorded from both colonoscopy reports and corresponding
histological examination of excised lesions.
Results: Data were extracted from colonoscopies in 2064 patients. Those aged <50 comprised 485 (24%) of the
total. CRC precursor lesions (including sessile serrated adenoma/polyps (SSA/P), traditional serrated adenomas,
tubular adenomas ≥10 mm or with high-grade dysplasia, and conventional adenomas with villous histology) were
seen in 4.3% of patients aged <50 and 12.9% of patients aged ≥50 (P <0.001). Among colonoscopies yielding CRC
precursor lesions in patients under 50 years, SSA/P occurred in 52% of procedures (11/21), compared with 27%
(55/204) of procedures in patients aged 50 and older (P = 0.02). SSA/P were proximally located in (10/11) 90% of
patients aged under 50, and 80% (43/54) of those aged 50 and older (P = 0.46).
Conclusions: SSA/P were the most frequently observed CRC precursor lesions in patients aged <50. Most CRCs in
this age group are known to arise in the distal colon and rectum suggesting that lesions other than SSA/P may
serve as the precursor for the majority of early-onset CRC.
Keywords: Adenoma, Sessile serrated adenoma, Early-onset colorectal cancer
Background
Colorectal cancer (CRC) in young adults (diagnosed before
age 50 years) accounts for 7.5% of the total CRC burden in
the Australian population [1], and its incidence has been in-
creasing during the last two decades in both Australia and
the USA [2–4]. Though the early age of onset for CRC is
thought to reflect an increased genetic predisposition, the
majority appear to be sporadic [5, 6]. CRC in young adults
associated with known hereditary conditions such as Lynch
syndrome comprises a minor component (15–17%) [7–10],
whilst a further subset of cases have a clear familial basis
with no attributable genetic aetiology [11]. Some authors
have raised the possibility that sporadic early-onset CRC
may result from the inheritance of multiple predisposing
genetic variants, both rare and common [12], rather than
the slow accumulation of somatic changes seen in sporadic
CRC from older patients. Attempts to identify rare predis-
posing variants outside the known genetic syndromes have
been undertaken on CRC patients under 40 years of age,
and have encountered considerable heterogeneity, with few
rare loss-of-function variants being recurrent [13]. Hence
the origin of most early-onset CRC remains unexplained.
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A number of authors have suggested that early-onset
CRC is a distinct entity based on clinico-molecular
analyses [14, 15]. Early-onset CRC occurs more fre-
quently in the distal colorectum compared with CRC in
older adults [3]. In addition, the CRC are more likely to
display mucinous and signet ring cell differentiation, and
high histologic grade. Early-onset CRC has also been
reported to have a different molecular profile than that
occurring in older adults [11]. In particular, early-onset
CRC demonstrates less frequent BRAF mutation (7% vs
19%) and more frequent isolated PIK3CA/PTEN mutation
(16% vs 1%) than tumours from patients aged over 70 at
CRC diagnosis [16]. CRC develop from two major sub-
classes of precursor lesions; conventional adenomas and
serrated polyps. The molecular pathogenesis of CRC
frequently reflects the lesion from which the CRC arises;
however, studies of precursor lesion histological subtypes
in the young are limited, as this age group is not undergo-
ing population screening. Lesion subtypes are associated
with a number of lifestyle risk factors [17, 18], and there-
fore may be studied to provide clues to the triggers for
early-onset colorectal neoplasia. The aim of this study was
to document the prevalence, location and histological
subtype of CRC precursor lesions in patients undergoing
colonoscopy before age 50 years in a hospital colonoscopy
service and compare the findings with those from patients
aged 50 years and older, with a view to increasing the
current understanding of bowel neoplasia in young adults
and seeking clues to its potential risk factors.
Methods
This is a cross-sectional study using an audit of 2613 pro-
cedures recorded within the colonoscopy database at The
Queen Elizabeth Hospital (a tertiary teaching hospital) in
Adelaide, South Australia over a 12-month period from
March 2013. Data from each procedure were extracted in
sequence by a gastroenterology registrar (SW) and re-
corded in a purpose-dedicated database. Findings were
obtained from both the colonoscopy report within a
ProVation endoscopy procedure documentation system
(Wolters Klewer) [19], and the corresponding pathology
report concerning histological examination of excised
lesions. Lesion sizes were derived from colonoscopy re-
ports. Indications for colonoscopy were derived from
admission notes in ProVation including self-reported
family history of CRC (any non-specified relative with
CRC), personal medical history of colonic neoplasia,
bowel symptoms (pain, change of habit, diarrhoea,
constipation), occult or overt bleeding, confirmed iron-
deficiency anaemia, and confirmed or suspected inflam-
matory bowel disease. The study was approved by the
Human Research Ethics Committee of the Central
Adelaide Local Health Network under protocol number
HREC/14/TQEHLMH/194.
Definitions
Lesion subtypes were reported on a per colonoscopy
basis. Any serrated lesion included hyperplastic polyps,
sessile serrated adenoma/polyps (SSA/P) and traditional
serrated adenomas (TSA) [20]. Any conventional aden-
oma comprised conventional adenomas with tubular
and/or villous histology and low- or high-grade dyspla-
sia. CRC precursor lesions (CPL), comprised SSA/P with
or without dysplasia, TSA, tubular adenomas ≥10 mm in
size or with high-grade dysplasia (ATA) and any conven-
tional adenoma with villous histology (TVA or VA).
Proximal colon refers to caecum, ascending colon, and
transverse colon. Distal colon refers to splenic flexure,
descending colon, sigmoid colon and rectum.
Statistical analysis
Prevalence of characteristics of patients, indications for
colonoscopy and findings were compared between two
groups (<50 vs ≥50 years) using Pearson’s chi-squared
test. Continuous variables were compared using a t-
test. All statistical association tests were performed
using SPSS Version 23 for Mac (IBM). Two-tailed sta-
tistics were used throughout with a significance level
of P-value <0.05.
Results
Of the total 2613 available reports, 398 (15%) were ex-
cluded due to incomplete data, and a further 77 proce-
dures (3%) were not completed due to poor bowel
preparation, looping or patient discomfort, leaving 2138
complete procedures (82%). Within this group, sixty-six
patients underwent multiple colonoscopies during the
study period. In instances of multiple procedures, data
were drawn from the initial procedure only, leaving a
total of 2064 individual patients whose data contributed
to the study. Characteristics of patients and colonoscopy
findings are given in Table 1.
Indications
Patients aged <50 were more likely to be having a pro-
cedure for family history of CRC (P = 0.001), whereas
those aged ≥ 50 years were more likely to have a
personal history of CRC or polyps (P <0.001). Five
patients were known to have a DNA mismatch repair
gene mutation (Lynch syndrome) prior to the proced-
ure, and all were females and aged under 50 years.
Confirmed or suspected inflammatory bowel disease,
abdominal pain and change in bowel habit were more
frequently reported as an indication for colonoscopy in
young patients (P <0.001 in all instances). Young
patients had a higher prevalence of overt bleeding as
an indication for their procedure (P <0.001), whereas
older patients demonstrated a higher prevalence of
occult bleeding (P <0.001).
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Precursor polyps and cancers
Histologically confirmed neoplastic lesions were ob-
served in 16.5% (80/485) of patients aged <50 and 37%
(584/1579) of patients aged ≥50 (P <0.001) (Table 1).
Polyps known to serve as CRC precursor lesions (CPL)
were seen in 4.3% (21/485) of patients aged <50 and
12.9% (204/1579) of patients aged ≥50 (P <0.001). When
all polyps were assessed according to subtype, there was
no evidence for a difference in serrated polyp prevalence
(any serrated subtypes including hyperplastic polyps)
when data were partitioned at age 50 (P = 0.21). In con-
trast, conventional adenomas were more prevalent in
the older age group (P <0.001). The distribution of CPL
subtypes also differed between age groups (Table 1 and
Fig. 1). The prevalence in the study population of SSA/P
did not differ between the two age groups (P = 0.20) but
both TVA (P <0.001) and ATA (P <0.001) were more
prevalent in the older age group (Fig. 1a,b). SSA/P were
removed from 11/21 (52%) colonoscopies bearing known
precursor lesions in patients <50 year, compared with
55/204 (27%) colonoscopies in patients aged 50 and
older (P = 0.02) (Fig. 1c). SSA/P were located in the
proximal colon in 90% of cases within the patient group
aged <50 years, and in 80% in those aged ≥50 (P = 0.45).
Average size of SSA/P in the <50 age group was 6.8 mm
(range 2–15 mm) and in those aged ≥50 was 8.7 mm
Table 1 Characteristics of patients, and polyp findings in each age group
All % Age <50 % Age ≥50 % P-value <50 vs ≥50
Totals n = 2064 n = 485 n = 1579
Mean age 59.7 39.2 66.0
Median age 60 42 65
Age range 18–96 18–49 50–96
Sex Males 984 47.6 220 45.4 764 48.4 0.13
Females 1080 52.4 265 54.6 815 51.6
Indications
IBD 90 4.4 49 10.1 41 2.6 <0.001
Overt bleeding 348 16.8 108 22.2 240 15.2 <0.001
Occult bleeding 350 16.9 29 5.9 321 20.3 <0.001
Pain 227 11 77 15.9 150 9.5 <0.001
Bowel habit 194 9.4 74 15.3 120 7.6 <0.001
FH CRC 117 5.7 42 8.7 75 4.8 0.001
PH CRC 83 4 4 0.8 79 5 <0.001
PH polyps 303 14.9 34 7 274 17.4 <0.001
Findings
Any polyps 714 34.6 80 16.5 584 37 <0.001
Serrated polyps 205 9.9 41 8.5 164 10.4 0.21
Conventional adenomas 523 25.3 46 9.5 477 30.2 <0.001
Multiple polyps 406 19.7 35 7.2 371 23.5 <0.001
CPL 225 10.9 21 4.3 204 12.9 <0.001
Polyp sub-types
SSA/P 65 3.1 11 2.3 54 3.4 0.20
TSA 1 0.01 0 0 1 0.06
TVA 95 4.6 8 1.6 87 5.5 <0.001
ATA 76 3.7 3 0.6 73 4.6 <0.001
VA 2 0.01 0 0 2 0.13
Cancers
CRC 55 2.7 5 1 50 3.2 0.01
Distal CRC Site 28 49.1 4 80 24 48.1 0.35
IBD Inflammatory bowel disease (Crohns disease, ulcerative colitis, NOS), FH CRC Family history of CRC, PH CRC Personal history of CRC, PH Polyps Personal history
of polyps, CPL known CRC precursor lesions, SSA/P Sessile serrated adenoma/polyps, TVA Tubulovillous adenoma, ATA Advanced tubular adenoma (≥10 mm, and/
or high-grade dysplasia), TSA Traditional serrated adenoma, VA Villous adenoma
Significant p-values are shown in italics
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(range 2–25 mm) (P = 0.36). There was no difference
between the prevalence of SSA/P in each sex overall
(P = 0.35) or within the younger patient age group
(P = 0.59). The prevalence of CPL or CRC did not
differ between the sexes in patients aged <50, how-
ever males were more likely than females to develop
CPL or CRC in patients aged ≥50 years (P = 0.007)
(Table 2). The service-based adenoma detection rate
was 297/984 (30%) for males and 226/1080 (21%)
for females.
CRC was detected in 1.0% (5/485) of patients aged <50
vs 3.2% (50/1579) of patients aged ≥50 (P = 0.01).
Colonoscopy-detected CRC in patients aged <50 was
found in the distal colon in 4/5 (80%) compared with
24/50 (48%)(P = 0.35). Of the five patients known to
have Lynch syndrome, only one was found to have CRC
in the setting of long-standing ulcerative colitis, and the
remaining four patients showed no pathology. All high-
grade dysplasia in the audit was observed in the older
age group in 16 polyps from 15 patients (12 females;
average age 74). The polyps comprised 4 tubular
adenomas and 11 tubulovillous adenomas. In addition,
several rare polyp types were observed during the audit
including a single, proximally located SSA/P with
dysplasia in a 67 year old female, a villous adenoma in a
79 year old female, and a traditional serrated adenoma
in a 51 year old female.
Synchronously occurring lesion types
The co-occurrence of CPL subtypes in patients in each
age group is shown in Table 3. Having at least one SSA/
P was associated with any conventional adenoma across
all patients (P = 0.002), with any conventional tubular
adenoma (P = 0.001), whilst there was no evidence for an
association with advanced tubular adenomas (P = 0.09)
or tubulovillous adenomas (P = 0.99). The association
between SSA/P and any conventional adenoma or any
tubular adenoma remained significant when patients
≥50 years were considered (P = 0.02 and P = 0.008
respectively) but failed to attain statistical signi-
ficance when patients aged under 50 years were
analysed (P = 0.08 and P = 0.05 respectively). Co-
occurrence between conventional adenomas, or tubu-
lar adenomas, and SSA/P was present regardless of
family history of CRC.
Bleeding and polyp types
Patients who were having a colonoscopy for occult or
active bleeding were more likely to have been diagnosed
with CPL or CRC (P = 0.005) compared with patients
not reporting any bleeding. This finding was seen in the
older age group (P = 0.03), though not in younger pa-
tients (P = 0.18). When bleeding was stratified into
overt and occult forms, occult bleeding was associated
with CPL or CRC (P = 0.03), or with advanced con-
ventional adenoma specifically (P = 0.009), in patients
diagnosed at ≥50 years, but there was no evidence for
this association in patients under 50 years. No associ-
ations emerged between bleeding and SSA/P in either
age group (P = 0.99)(Table 4).
Fig. 1 Distribution of Polyp Subtypes. Graphs showing the
distribution of polyp subtypes a across all colonoscopies
partitioned by age group, b within the colonoscopies which
yielded known CRC precursor lesions (CPL) partitioned by age
group and c the percentage of colonoscopies which yielded the
three major subtypes of CRC precursor lesions, SSA/P, TVA and
ATA across the lifespan. SSA/P sessile serrated polyp, TVA
tubulovillous adenoma, ATA advanced tubular adenoma
(≥10 mm or high-grade dysplasia)
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Family history of CRC
There was no evidence for association between family his-
tory of CRC and CPL, or CRC specifically, in those aged
under 50 at colonoscopy. There was some evidence for
patients aged 50 and older to have an association between a
family history of CRC and a diagnosis of CRC specifically
(P = 0.08). SSA/P showed an association with family history
of CRC (P = 0.04) in those aged 50 and older. No evidence
for an association between family history of CRC and
conventional adenomas was observed in either age group.
Discussion
The results of this study suggest that, in contrast to older
patients, SSA/P comprise a significantly higher proportion
of the known CRC precursors [21] removed from patients
aged under 50 in a routine colonoscopy service. Overall,
SSA/P prevalence did not differ between the two age groups
in the study, whereas advanced adenoma prevalence
increased steadily with age, in parallel to some degree with
the higher prevalence of cancer in the older age group, and
consistent with what would be expected in the general
population. A similar pattern to these observations has been
reported previously among all polyp subtypes [22]. In a
retrospective cohort of 28,544 asymptomatic patients from
Korea aged 20-88 years, and undergoing a work-related
health check, the prevalence of serrated lesions was seen to
be higher than that of conventional adenomas in youngest
age groups, and to increase only slightly with age. Conven-
tional adenomas, in contrast, had a lower prevalence than
serrated polyps in the youngest age group and increased in
prevalence with increasing age. The authors of the Korean
study concluded that serrated polyp prevalence, including
that of SSA/P, were relatively high in patients aged under
50 years. Though extensive studies have been reported from
Asian cohorts which document colorectal neoplasia in
patients aged under 50 years [22–24], this current study
reports the findings at colonoscopy in young adults from a
predominantly Caucasian population. The prevalence of
hyperplastic (serrated) polyps per se observed in this study
is comparable with that reported by Wong et al [23], how-
ever a recent report from Australia suggests that SSA/P
subtype is relatively rare in Chinese patients when com-
pared with Caucasians [25].
In both age groups, approximately 80% of SSA/P arose
in the proximal colon. In patients under 50 with CRC,
the majority of malignant lesions was observed in the
distal colon and rectum in this report, and this is con-
sistent with the current understanding that early-onset
Table 2 Medium to high-risk polyps or cancer grouped by sex and age
Group Males Percentage with CPL or cancer Females Percentage with CPL or cancer P-value*
<50 years 11 5 15 5.7 0.75
≥50 years 140 18.3 109 13.4 0.007
All 151 15.3 124 11.5 0.01
*Comparison of proportion of each feature between males and females
CPL known CRC precursor lesions
Significant p-values are shown in italics
Table 3 Co-occurrence of adenoma subtypes with SSA/P in patients with conventional adenomas
SSA/P co-occurring with… SSA/P present (n) (%) SSA/P absent (n) (%) P-value*
Any AD <50 years 3/11 27.3 43/474 9.1 0.08
≥50 years 25/55 46.3 452/1523 29.7 0.02
All 28/66 43.1 495/1997 24.8 0.002
Any TA <50 years 3/11 27.3 37/474 7.8 0.05
≥50 years 24/55 44.4 403/1524 26.4 0.008
All 27/66 41.5 440/1998 22.0 0.001
ATA <50 years 1/11 9.1 2/474 0.4 0.07
≥50 years 4/55 7.4 69/1524 4.5 0.32
All 5/66 7.7 71/1998 3.6 0.09
TVA <50 years 0/11 0.0 8/485 1.7 0.99
≥50 years 3/55 5.6 84/1524 5.5 0.99
All 3/66 4.6 92/1998 4.6 0.99
*Comparison of proportions of specified condition present (i.e. SSA/P present among those with any adenoma, any tubular adenoma, an advanced tubular
adenoma, or a tubulovillous adenoma) between young adults (<50 years) and older adults (≥50 years) compared to patients with the specified adenoma only
SSA/P sessile serrated adenoma/polyp, Any AD any conventional adenoma, Any TA any tubular adenoma, ATA advanced tubular adenoma (≥10 mm and/or
high-grade dysplasia), TVA tubulovillous adenoma
Significant p-values are shown in italics
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CRC is predominantly a malignancy of the distal large
bowel [3, 12, 26, 27]. SSA/P, being located in the proximal
colon in young adults, are therefore unlikely to be the pre-
cursor lesion for most early-onset CRC. In support of this
premise, somatic BRAF mutation, the molecular genetic
hallmark of SSA/P, is relatively rare in CRC from young
adults, being present at (3/45) 7% in a Norwegian study
[16], 1/68 (2%) in a Spanish report [8], and in 0/39 (0%)
from France [14]. Activating mutations in BRAF are present
in 14–16% of all population-based CRC [28, 29].
It is not known for certain whether SSA/P have always
been present in young patients undergoing colonoscopy.
Indeed, growing awareness of SSA/P has occurred only
in recent decades, and may have contributed to this
observation. Alternatively, the presence of SSA/P in
young patients may be a surrogate marker for mucosal
abnormalities and future risk of advanced neoplasia,
related to an emerging population risk factor among
young adults. Smoking has been consistently associated
with SSA/P, and, though it is thought by some authors
that the induction time in young adults is insufficient to
produce neoplasia [3, 30, 31], a recent report has pre-
sented evidence that it may be a contributory factor
[32]. Associations between obesity and diabetes and a
diagnosis of SSA/P have been reported inconsistently
[33, 34]. However, metabolic risk scores for prediction of
advanced colorectal neoplasia demonstrate their greatest
effects in patients aged under 60 years [35]. More
recently, diabetes has been identified as an independent
risk factor for colorectal neoplasia in patients aged 40–
49 years [23] and diabetes has been identified elsewhere
as a risk factor for early-onset CRC [36].
The study also incidentally highlights a number of
features of SSA/P. It presents indirect evidence for a
prolonged dwell time for these lesions, and suggests that
SSA/P may arise early and be present in the colon for
decades without a significant increase in size [37]. Bleed-
ing as an indication for colonoscopy was not associated
with SSA/P in our data [38], in contrast to this symptom
showing a significant association with advanced conven-
tional adenomas. In addition, the study confirms a previ-
ous observation of an association between SSA/P and a
family history of CRC [39], though this was not apparent
in patients under 50. In patients under 50, the lower
overall age of first-degree relatives may be a contributing
factor to this observation.
The study observed a significant likelihood for SSA/P
to co-occur with non-villous conventional adenomas
specifically, though association between SSA/P and con-
ventional adenomas generally has long been recognised
[38, 40–44]. A recent report provided indirect evidence
for our finding in that conventional adenomas which
occur synchronously with SSA/P lack KRAS mutation
[45] which is a known feature of villous histology [46]. A
further report has shown that proximal serrated polyps
have been associated with multiple non-advanced con-
ventional adenomas in Chinese patients [43]. These
findings may be related to a predisposed mucosa [47],
and as such may serve as a marker for increased risk of
advanced neoplasia, rather than as precursors per se.
The presence of small SSA/P in association with a small
tubular adenoma has recently been associated with a
significantly increased rate of metachronous advanced
neoplasia during surveillance when compared to small
tubular adenomas alone (18.2% vs 7.8%, P = 0.02). In
addition, the presence of small SSA/P had a risk of
metachonous advanced neoplasia comparable with an
index high-risk conventional adenoma (17.9% for a small
Table 4 Associations between significant neoplasia and bleeding observations in patients with bleeding
Age <50 % P-value Age ≥50 % P-value All % P-value
n= n= n=
Totals Patients with bleeding 137 561 698
Any bleeding With CPL/CRC 10 7.3 0.18 101 18.0 0.03 111 15.9 0.005
With SSA/P 5 3.6 0.2 17 3.0 0.53 22 3.2 0.99
With AA 4 2.9 0.54 65 11.6 0.03 69 9.9 0.008
Totals Patients with overt bleeding n = 108 n = 240 n = 348
Overt bleeding With CPL/CRC 8 7.4 0.17 40 16.7 0.31 48 13.8 0.34
With SSA/P 4 3.7 0.21 8 3.3 0.56 12 3.4 0.42
With AA 4 3.7 0.21 23 9.6 0.49 27 7.8 0.52
Totals Patients with occult bleeding n = 29 n = 321 n = 350
Occult bleeding With CPL/CRC 2 6.9 0.45 61 19.0 0.03 63 18.0 0.002
With SSA/P 1 3.4 0.5 9 2.8 0.31 10 2.9 0.44
With AA 0 0.0 0.5 42 13.1 0.009 42 12.0 0.001
CPL/CRC CRC precursor lesions and/or CRC, SSA/P sessile serrated polyp, AA advanced conventional adenoma (≥10 mm or high-grade dysplasia or villous histology)
Significant p-values are shown in italics
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isolated SSA/P vs 15.9% for a high-risk conventional
adenoma) [48]. It has been suggested that isolated small
SSA/P therefore be considered for new surveillance
interval recommendations [48]. These observations high-
light the clinical relevance of findings in our current study,
as there may be potential benefit of increased longitudinal
follow-up in young adults with SSA/P, regardless of size.
That there was no association between SSA/P and aden-
omas with villous histology may reflect genetic back-
ground in patients who develop SSA/P [49].
A previous report has suggested that rectal bleeding is
less useful for prediction of advanced neoplasia in
patients under 50 years [50], and this observation has
also emerged in our study. The differences in occult
versus active bleeding may have some implications when
we look at mechanisms to reduce the impact from an
increasing rate of CRC in patients aged under 50 years.
Only 6% of those <50 years had occult bleeding com-
pared to 20.3% for those aged over 50 years (p = <0.001).
The low rate may reflect a lower uptake of the testing,
as expected, because young patients are not undergoing
screening. It also highlights a difference in timing of
presentation with younger patients more likely to await
symptoms and there is evidence of more advanced
disease potentially supportive of this [51]. Although
education around testing for occult bleeding will still be
relevant, more general education approaches around
screening, symptoms and early presentation to a health
care provider may be just as important, both targeting
patients and the health care profession, and may involve
other markers of increased risk such as family history of
malignancy and personal history of diabetes.
The study has a number of limitations. Patients under
50 are undergoing procedures for a different range of
indications, although this does reflect real world prac-
tice. The number of young adults with neoplastic find-
ings was relatively low and may have affected the power
of a subset of comparisons. However, the presence of
SSA/P in young adults is an important observation
which has the potential to identify those aged under 50
who are at higher than population risk. In addition, the
population did not include cases of advanced neoplasia
diagnosed by sigmoidoscopy or imaging, and it is diffi-
cult to know whether this has influenced the ability to
generalise to all young adults undergoing investigations.
Colonoscopies were performed at a single tertiary centre
involving multiple colonoscopists, and individual aden-
oma detection rates were not available. However, our
service-based adenoma detection rate is within the up-
dated limits suggested for a quality colonoscopy service
of at least 30% for males and 20% for females [52].
Family history was self-reported and not systematically
verified, and indications for colonoscopy were extracted
from admission notes. Allowing for these limitations,
results showed that adenoma prevalence rises with age,
and this is in keeping with what would be expected in
the general population [53]. This report also confirms
a recent publication demonstrating that advanced
polyps in patients under 45 are more likely to be
sporadic than associated with family history, as family
history of CRC was reported in 7.1% of those with
any advanced neoplasia [54].
Conclusions
In summary, proximal SSA/P comprised a greater pro-
portion of lesions with malignant potential in patients
under age 50, compared with older patients. However
most CRC in this age group occurs in the distal colon
and rectum, both in this study, and consistently in the
literature [3, 12, 26, 27], suggesting that SSA/P are unlikely
to serve as the premalignant lesion for the majority of early-
onset CRC, but may have a potential role as markers of
future increased risk for advanced neoplasia. Further, SSA/
P in both age groups co-occurred significantly with con-
ventional non-villous adenomas, a combination with
increased risk for subsequent advanced neoplasia [48].
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